Amylyx Pharmaceuticals, Inc. AMLX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s financing cash flow?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported financing cash flow of $3.22M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s financing cash flow decreased by 95.1% year-over-year, from $65.66M to $3.22M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s financing cash flow?
- Over 2 years (2021 to 2024), Amylyx Pharmaceuticals, Inc.'s financing cash flow has grown at a -95.3% compound annual growth rate (CAGR), from $159.57M to $348K.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.